Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Cyclosporin is effective for treating skin conditions in small animals, but requires careful dosing and monitoring for side effects.

Finasteride affects alcohol intake in male mice, possibly due to neurosteroids.

DHT, a testosterone byproduct, causes male pattern baldness.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Endo-HSE helps grow hair-like structures from human skin cells in the lab.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Skin problems can be linked to sexual abuse, requiring careful medical and psychological evaluation.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

Finasteride doesn't affect hormone levels in normal men.

Most hair loss in captive rhesus macaques is likely due to environmental and behavioral factors.